Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.

Citation data:

Best practice & research. Clinical obstetrics & gynaecology, ISSN: 1532-1932, Vol: 44, Page: 57-67

Publication Year:
2017
Usage 6
Abstract Views 4
Link-outs 2
Social Media 5
Tweets 5
PMID:
28302443
DOI:
10.1016/j.bpobgyn.2017.02.006
Author(s):
Chokoshvili, Davit, Vears, Danya F, Borry, Pascal
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
review description
Since the introduction of out-of-hospital health-related genetic tests more than a decade ago, the landscape of genetic testing services has grown in complexity. Although initially most genetic tests for health purposes were offered as direct-to-consumer services, that is, without the mediation of a medical professional, currently many commercial providers require that their tests be ordered by a licensed physician. At the same time, some commercially developed health-related genetic tests are gaining support from the professional medical community and are finding their way into clinical practice. Therefore, we differentiated between three types of genetic testing offers: direct-to-consumer, physician-mediated, and clinic-based genetic testing. Expanded carrier screening tests for recessive disorders are currently available through all the three models of genetic testing. Herein, we review the present landscape of expanded carrier screening offers by highlighting the distinct issues associated with each of the three types of genetic testing.

This review has 0 Wikipedia mention.